| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Istituto di Endocrinologia (Da.P., V.R., A.B., A.A.S.), Dipartimento di Biochimica e Biofisica (V.G.), Seconda Universitá di Napoli; Istituto di Urologia, Universitá Federico II (D.P., T.L.); and Dipartimento di Biochimica e Biotecnologie Mediche-Centro di Ingegneria Genetica, Università Federico II (V.C.), 80131 Naples, Italy
Address all correspondence and requests for reprints to: Antonio A. Sinisi, M.D., Istituto di Endocrinologia, Seconda Universitá di Napoli, Building 16, Via Pansini 5, 80131 Naples, Italy. E-mail: sinisi{at}unina.it
We treated primary epithelial cells from human normal prostate (NEPC)
and prostate cancer (CEPC) with all-trans-retinoic acid
(RA) to study whether it regulates the activity of tissue
transglutaminase (tTGase), an enzyme that accumulates in cells
undergoing apoptosis. tTGase activity was assessed by
[14C]spermidine incorporation; tTGase, P53, Bcl-2,
and p21 protein levels were evaluated by Western blotting; and RA
receptors (RAR
, -ß, and -
), tTGase, retinol-binding protein
(RBP), and cellular RBP type I transcripts were determined by
semiquantitative RT-PCR. After 7296 h of 10-6 mol/L RA
treatment, cell growth inhibition and apoptosis were associated with
increased tTGase activity in both NEPC and CEPC, and with increased
tTGase protein and messenger ribonucleic acid levels only in NEPC.
Moreover, RA down-regulated RAR
and -ß and increased RBP messenger
ribonucleic acid levels in NEPC, whereas it increased RARß gene
expression and decreased Bcl-2 protein levels in CEPC. Our results
suggest that RA induces tTGase gene expression and enzyme activity in
normal prostate cells, and that RA-regulated pathways are impaired in
cancer cells. Moreover, down-regulation of Bcl-2 protein and
up-regulation of RARß suggest that retinoid may act on the genetic
defect responsible for prostate cancer progression.
This article has been cited by other articles:
![]() |
D. Pasquali, V. Rossi, S. Staibano, G. De Rosa, P. Chieffi, D. Prezioso, V. Mirone, M. Mascolo, D. Tramontano, A. Bellastella, et al. The Endocrine-Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF)/Prokineticin 1 and 2 and Receptor Expression in Human Prostate: Up-Regulation of EG-VEGF/Prokineticin 1 with Malignancy Endocrinology, September 1, 2006; 147(9): 4245 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Avila, X. Zheng, X. X. Cui, A. D. Ryan, A. Hansson, J. Suh, A. B. Rabson, R. L. Chang, W. J. Shih, Y. Lin, et al. Inhibitory Effects of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans Retinoic Acid on the Growth of Cultured Human Pancreas Cancer Cells and Pancreas Tumor Xenografts in Immunodeficient Mice J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 170 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pasquali, P. Chieffi, W. J Deery, G. Nicoletti, A. Bellastella, and A. A Sinisi Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells Eur. J. Endocrinol., April 1, 2005; 152(4): 663 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zheng, R. L. Chang, X.-X. Cui, G. E. Avila, S. Lee, Y. P. Lu, Y. R. Lou, W. J. Shih, Y. Lin, K. Reuhl, et al. Inhibitory Effect of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans-Retinoic Acid on the Growth of LNCaP Prostate Tumors in Immunodeficient Mice Cancer Res., March 1, 2004; 64(5): 1811 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. E. McFadyen, W. T. Melvin, and G. I. Murray Cytochrome P450 enzymes: Novel options for cancer therapeutics Mol. Cancer Ther., March 1, 2004; 3(3): 363 - 371. [Abstract] [Full Text] |
||||
![]() |
B. R. Haugen, L. L. Larson, U. Pugazhenthi, W. R. Hays, J. P. Klopper, C. A. Kramer, and V. Sharma Retinoic Acid and Retinoid X Receptors Are Differentially Expressed in Thyroid Cancer and Thyroid Carcinoma Cell Lines and Predict Response to Treatment with Retinoids J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 272 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Alfaro, B. Fraile, M. V. T. Lobo, M. Royuela, R. Paniagua, and M. I. Arenas Immunohistochemical Detection of the Retinoid X Receptors {alpha}, {beta}, and {gamma} in Human Prostate J Androl, January 1, 2003; 24(1): 113 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Johnson, R. P. Walker, S. W. Jones, K. Stephens, J. Meurer, D. A. Zajchowski, M. M. Luke, F. Eeckman, Y. Tan, L. Wong, et al. Multiplex Gene Expression Analysis for High-Throughput Drug Discovery: Screening and Analysis of Compounds Affecting Genes Overexpressed in Cancer Cells Mol. Cancer Ther., December 1, 2002; 1(14): 1293 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pasquali, A. Notaro, G. Bonavolonta', P. Vassallo, A. Bellastella, and A. A. Sinisi Somatostatin Receptor Genes Are Expressed in Lymphocytes from Retroorbital Tissues in Graves' Disease J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5125 - 5129. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Kedishvili, O. V. Chumakova, S. V. Chetyrkin, O. V. Belyaeva, E. A. Lapshina, D. W. Lin, M. Matsumura, and P. S. Nelson Evidence That the Human Gene for Prostate Short-chain Dehydrogenase/Reductase (PSDR1) Encodes a Novel Retinal Reductase (RalR1) J. Biol. Chem., August 2, 2002; 277(32): 28909 - 28915. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ou, J. Haendeler, M. R. Aebly, L. A. Kelly, B. C. Cholewa, G. Koike, A. Kwitek-Black, H. J. Jacob, B. C. Berk, and J. M. Miano Retinoic Acid-Induced Tissue Transglutaminase and Apoptosis in Vascular Smooth Muscle Cells Circ. Res., November 10, 2000; 87(10): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lopez-Bermejo, C. K. Buckway, G. R. Devi, V. Hwa, S. R. Plymate, Y. Oh, and R. G. Rosenfeld Characterization of Insulin-Like Growth Factor-Binding Protein-Related Proteins (IGFBP-rPs) 1, 2, and 3 in Human Prostate Epithelial Cells: Potential Roles for IGFBP-rP1 and 2 in Senescence of the Prostatic Epithelium Endocrinology, November 1, 2000; 141(11): 4072 - 4080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |